Literature DB >> 7750536

DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu-and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors.

M Minami1, T Onogi, T Nakagawa, Y Katao, Y Aoki, S Katsumata, M Satoh.   

Abstract

The structural basis of opioid receptors (OPRs) for the subtype-selective binding of DAMGO, a mu-opioid receptor selective ligand, was investigated using chimeric mu/kappa-OPRs. Replacement of the region from the middle of the fifth transmembrane domain to the C-terminal of mu-OPR with the corresponding region of mu-OPR remarkably decreased the binding affinity to DAMGO, while the reciprocal chimera revealed the high affinity to DAMGO. These results indicate that DAMGO distinguishes between mu- and mu-OPRs at the region around the third extracellular loop, different from the case of the distinction between mu-and delta-OPRs in which the region around the first extracellular loop is important. Furthermore, displacement studies revealed that the region around the third extracellular loop is involved in the discrimination between mu- and kappa-OPRs not only by peptidic mu- selective ligands but also by non-peptidic ligands, such as morphine and naloxone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7750536     DOI: 10.1016/0014-5793(95)00340-f

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

Review 1.  Homology modeling of opioid receptor-ligand complexes using experimental constraints.

Authors:  Irina D Pogozheva; Magdalena J Przydzial; Henry I Mosberg
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

2.  Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists.

Authors:  P A Claude; D R Wotta; X H Zhang; P L Prather; T M McGinn; L J Erickson; H H Loh; P Y Law
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Involvement of NOX1/NADPH oxidase in morphine-induced analgesia and tolerance.

Authors:  Masakazu Ibi; Kuniharu Matsuno; Misaki Matsumoto; Mika Sasaki; Takayuki Nakagawa; Masato Katsuyama; Kazumi Iwata; Jia Zhang; Shuji Kaneko; Chihiro Yabe-Nishimura
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

4.  The role of the hydrophilic Asn230 residue of the mu-opioid receptor in the potency of various opioid agonists.

Authors:  J Pil; J Tytgat
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

5.  A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function.

Authors:  Chris M Brasel; Gregory W Sawyer; Craig W Stevens
Journal:  Eur J Pharmacol       Date:  2008-10-09       Impact factor: 4.432

6.  Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.

Authors:  W W Wang; M Shahrestanifar; J Jin; R D Howells
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

7.  Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord.

Authors:  Kori L Brewer; Christine A Baran; Brian R Whitfield; A Marley Jensen; Stefan Clemens
Journal:  Front Neural Circuits       Date:  2014-06-11       Impact factor: 3.492

8.  Structure of the µ-opioid receptor-Gi protein complex.

Authors:  Antoine Koehl; Hongli Hu; Shoji Maeda; Yan Zhang; Qianhui Qu; Joseph M Paggi; Naomi R Latorraca; Daniel Hilger; Roger Dawson; Hugues Matile; Gebhard F X Schertler; Sebastien Granier; William I Weis; Ron O Dror; Aashish Manglik; Georgios Skiniotis; Brian K Kobilka
Journal:  Nature       Date:  2018-06-13       Impact factor: 49.962

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.